Claims for Patent: 12,703,682
Summary for Patent: 12,703,682
| Title: | Crystalline form of sofpironium bromide and preparation method thereof |
| Abstract: | A cocrystal containing the 1′R-diastereomer and the 1′S-diastereomer of sofpironium bromide at a ratio of 1:3 (Form CO), a crystal mixture (for example, Form B) containing Form CO and a crystalline form of the 1′R-diastereomer (Form MN), and a method for preparing sofpironium bromide, which is suitable for manufacture of the crystal mixture are provided. Form CO and a crystalline form of sofpironium bromide containing Form CO (for example, Form B) have superior stability without hygroscopic property, and accordingly they can be preferably used as a raw material of medicaments. |
| Inventor(s): | Kazuyoshi MARUBAYASHI, Masahito Watanabe, Herbert R. Brinkman |
| Assignee: | Botanix Sb Inc , Kaken Pharmaceutical Co Ltd |
| Application Number: | US17/611,158 |
| Patent Claims: |
1. A stable crystal Form MN of a compound shown as formula I-a characterized by showing peaks at 7.1±0.1, 21.4±0.1, 22.3±0.1, and 24.5±0.1 as diffraction angles 2θ in a powder X-ray diffraction spectrum. 2. The crystal Form MN of claim 1, wherein the crystal is not hygroscopic. 3. The crystal Form MN of claim 1, wherein the crystal form is a physicochemically stable crystalline form. 4. The crystal Form MN of claim 1, wherein the purity of the crystal form is not less than 98% w/w based on the content of the compound (I), wherein the compound (I) is represented by the formula (I) 5. The crystal Form MN of claim 1, wherein a content of each compound represented by formulae III, IV and V is not more than 0.5% w/w based on a content of compound (I), wherein the compound (I) is represented by the formula (I) 6. The crystal Form MN of claim 1, wherein the total content of impurities is not more than 2.0% w/w based on a content of compound (I), wherein the compound (I) is represented by the formula (I) 7. A stable topical pharmaceutical composition comprising: a pharmaceutically effective amount of the crystal Form MN of claim 1 as an active pharmaceutical agent in a pharmaceutically acceptable carrier. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
